Polydrug Deaths & Supply-Side Interventions

Quarterly Insights from the RAND Drug Policy Research Center

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

August 2023

Three open bottles of prescription medication with pills spilling out, photo by sdominick/Getty Images

Polydrug Deaths & Supply-Side Interventions

A major supply-side intervention—Oxycontin reformulation—is linked to the increase in polysubstance overdose deaths involving non-opioid prescription drugs, specifically gabapentinoids and Z-drugs. Read more »

Psilocybin mushrooms displayed by a grower in Denver, Colorado, November 4, 2020, photo by Trevor Hughes/Reuters

Photo by Trevor Hughes/Reuters

State and Local Policy Is Changing for Psychedelics. What Will the Feds Do?

Psychedelics are attracting interest as a treatment for some mental health conditions. In response, some states and cities are changing their laws and policies on the supply and use of these mind-altering substances. But like cannabis, most psychedelics are federally prohibited—raising some tough questions for the federal government.

Read More »

Cannabis Shop Now Open sign, photo by Osarieme Eweka/Getty Images

Photo by Osarieme Eweka/Getty Images

Proximity to Legal Cannabis Stores and Sourcing of Cannabis in Canada

Legal cannabis stores are increasingly accessible to people living in Canada. Household proximity to a legal cannabis store was associated with sourcing cannabis from legal retail stores, but only among those who lived very close (less than 3km). While proximity to legal cannabis stores may aid uptake of the legal market, there may be diminishing returns after a certain distance.

Read more »

Close up photo female soldier leaning forward in seat, photo by SDI Productions/Getty Images

Photo by SDI Productions/Getty Images

Geographic Availability of Substance Use Disorder Treatment for Veterans

Jonathan Cantor testified before the U.S. Senate Committee on Veterans' Affairs on June 14, 2023 about veterans' proximity to substance use disorder treatment.

Watch the Video »

Bright colorful human hands over a floral pattern, design by Dori Walker/RAND Corporation from proksima/Getty Images

Design by Dori Walker/RAND Corporation from proksima/Getty Images

A Promising New Program Treats Co-Occurring Mental Health and Opioid Use Disorders

Helping people who have an opioid use disorder and either clinical depression or PTSD can often be challenging. A new collaborative care model called CLARO aims to help patients who otherwise might disappear into the cracks of the U.S. health care system.

Read More »

Trending Research

Investigating the Complexity of Naloxone Distribution

Longitudinal Effects of Social Network Changes on Drinking Outcomes for Individuals with a First-Time DUI

Treatment for Opioid Use Disorder Rises After Medicare Expands Coverage for Methadone

Risk and Protective Factors of Social Networks on Alcohol, Cannabis, and Opioid Use Among Urban American Indian/Alaska Native Emerging Adults

Evaluating the Closed Coffeeshop Chain Cannabis Experiment in the Netherlands

DPRC in the News

Women’s Problem Drinking Is Catching Up to Men's

Wall Street Journal

Medication for Opioid Use Disorder Dispensed More After Medicare Policy Change

HealthDay News

Politicians Want Cop Crackdowns on Drug Dealers. Experts Say Tough Tactics Cost Lives.

NPR, All Things Considered

How Fentanyl Changed the Game for Mexico’s Drug Cartels

Financial Times

Contact

Rosanna Smart

Rosanna Smart

Co-Director, RAND Drug Policy Research Center

Senior Economist

Beau Kilmer

Beau Kilmer

Co-Director, RAND Drug Policy Research Center

McCauley Chair in Drug Policy Innovation

Mafalda Pardal

Mafalda Pardal

RAND Europe Lead, RAND Drug Policy Research Center

Senior Analyst